Physician
Geisinger MT Pleasant Imaging, a Service of Geisinger Comm Med Center
Geisinger MT Pleasant Imaging, a Service of Geisinger Comm Med Center was paid $723K by Medicaid between Nov 2020 and Jun 2023, across 96 billing codes. Its largest line is 0202U, Oncology (prostate), multianalyte, gene expression profiling — 15% of everything it billed.
33Billing provider infoGEISINGER MT PLEASANT IMAGING, A SERVICE OF GEISINGER COMM MED CENTER
SCRANTON, PA 18503
SCRANTON, PA 18503
33aNPI1467850149assigned 12/12/2014
33bProvider typeDiagnostic Ultrasound Physician
28Total paid$723K
24GClaims20,565
24DCodes billed96
24AFirst – last monthNov 2020 – Jun 2023
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MULL, CINDY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 656 | $25K | |
| 2021 | 15,649 | $512K | |
| 2022 | 3,687 | $162K | |
| 2023 | 573 | $25K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 15% | 431 | 426 | $106K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 11% | 842 | 837 | $79K |
| 76642 | 11% | 1,431 | 1,170 | $78K | |
| 77066 | Tomosynthesis, mammo | 9.9% | 667 | 666 | $72K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 5.2% | 446 | 440 | $37K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 4.4% | 1,048 | 1,042 | $32K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 4.1% | 846 | 838 | $29K |
| 87481 | 2.8% | 304 | 255 | $20K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.7% | 840 | 822 | $20K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 2.6% | 521 | 510 | $19K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.4% | 781 | 763 | $17K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.2% | 692 | 683 | $16K |
84 more codes
| 76641 | 2.0% | 185 | $14K | |
| 77065 | Tomosynthesis, mammo | 1.9% | 181 | $14K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1.8% | 450 | $13K |
| 80053 | Comprehensive metabolic panel | 1.4% | 872 | $10K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 1.4% | 264 | $10K |
| 80061 | Lipid panel | 1.2% | 652 | $9K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.1% | 572 | $8K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 253 | $7K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 166 | $7K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 326 | $6K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 67 | $6K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 778 | $5K |
| 72100 | <1% | 179 | $5K | |
| 73630 | <1% | 298 | $4K | |
| 87511 | <1% | 190 | $4K | |
| 86803 | <1% | 188 | $4K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 436 | $4K |
| 82607 | <1% | 242 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 450 | $3K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 45 | $3K |
| 87150 | <1% | 72 | $3K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 41 | $3K |
| 82728 | <1% | 206 | $2K | |
| 76830 | Ultrasound, transvaginal | <1% | 41 | $2K |
| 85027 | <1% | 312 | $2K | |
| 84702 | <1% | 141 | $2K | |
| 83540 | <1% | 244 | $2K | |
| 73564 | <1% | 89 | $2K | |
| 87631 | <1% | 13 | $2K | |
| 72050 | <1% | 50 | $2K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 20 | $2K |
| 86003 | <1% | 13 | $2K | |
| 84439 | <1% | 216 | $2K | |
| 87522 | Neg quan hep c or qual rna | <1% | 40 | $2K |
| 80050 | General health panel | <1% | 33 | $2K |
| 86762 | <1% | 80 | $2K | |
| 87340 | <1% | 112 | $1K | |
| 86780 | <1% | 91 | $1K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 109 | $1K |
| 83550 | <1% | 242 | $1K | |
| 85610 | <1% | 289 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 117 | $1K |
| 84403 | <1% | 34 | $961.74 | |
| 82746 | <1% | 78 | $939.70 | |
| 82570 | <1% | 130 | $937.14 | |
| 82043 | <1% | 102 | $811.69 | |
| 76536 | <1% | 12 | $792.74 | |
| 73610 | <1% | 34 | $758.89 | |
| 82950 | <1% | 101 | $690.94 | |
| 84153 | <1% | 28 | $643.28 | |
| 83970 | <1% | 14 | $633.32 | |
| 84480 | <1% | 76 | $612.48 | |
| 82248 | <1% | 85 | $603.79 | |
| 86317 | <1% | 31 | $600.49 | |
| 84146 | <1% | 28 | $582.96 | |
| 86850 | <1% | 69 | $569.52 | |
| 86592 | <1% | 140 | $539.06 | |
| 85046 | <1% | 80 | $486.33 | |
| 83655 | <1% | 45 | $479.10 | |
| 81001 | <1% | 161 | $478.75 | |
| 83735 | <1% | 67 | $476.79 | |
| 83525 | <1% | 39 | $438.46 | |
| 84270 | <1% | 15 | $405.05 | |
| 88142 | <1% | 23 | $388.64 | |
| 87430 | <1% | 59 | $385.54 | |
| 86038 | <1% | 27 | $380.86 | |
| 86901 | <1% | 89 | $349.70 | |
| 85652 | <1% | 116 | $345.59 | |
| 86900 | <1% | 89 | $344.96 | |
| 83721 | <1% | 30 | $343.59 | |
| 86140 | <1% | 109 | $333.88 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 166 | $270.90 |
| 80076 | <1% | 28 | $254.34 | |
| 82565 | <1% | 38 | $252.67 | |
| 86431 | <1% | 30 | $238.96 | |
| 87186 | <1% | 25 | $238.40 | |
| 73130 | <1% | 21 | $193.62 | |
| 82951 | <1% | 14 | $174.95 | |
| 84630 | <1% | 12 | $168.57 | |
| 83520 | <1% | 12 | $145.05 | |
| 83690 | <1% | 26 | $135.70 | |
| 84425 | <1% | 18 | $133.14 | |
| 81003 | <1% | 36 | $114.60 | |
| 82952 | <1% | 14 | $45.77 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMULL, CINDY (DIRECTOR, REVENUE CYCLE)
| Provider | Location | Paid |
|---|---|---|
| Geisinger Clinic | Danville, PA | $74.54M |
| Community Medical Center | Scranton, PA | $22.62M |
| Geisinger Clinic | Danville, PA | $14.93M |
| West Shore Advanced Life Support Services, INC. | Danville, PA | $4.41M |
| Geisinger Clinic | Pottsville, PA | $3.39M |
| Geisinger Clinic | Lewistown, PA | $2.93M |
| Geisinger Clinic | Scranton, PA | $2.63M |
| Geisinger Clinic | Wilkes Barre, PA | $2.35M |
| Geisinger Clinic | Danville, PA | $2.28M |
| Geisinger Jersey Shore Hospital | Jersey Shore, PA | $2.17M |
| Geisinger Clinic | Scranton, PA | $1.71M |
| Geisinger Clinic | Tunkhannock, PA | $1.11M |
| Geisinger Clinic | Orwigsburg, PA | $974K |
| Geisinger Clinic | Pittston, PA | $942K |
| Geisinger Clinic | Berwick, PA | $896K |
| Geisinger Clinic Selinsgrove | Selinsgrove, PA | $819K |
| Geisinger Clinic | Philipsburg, PA | $678K |
| Geisinger Clinic | Lewisburg, PA | $557K |
| Geisinger Clinic | Mountain Top, PA | $523K |
| Geisinger Clinic | Kulpmont, PA | $489K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.